Literature DB >> 6887697

Urea movement across erythrocyte membrane during artificial kidney treatment.

A K Cheung, M F Alford, M M Wilson, J K Leypoldt, L W Henderson.   

Abstract

Previous work by other investigators indicates that erythrocyte urea and creatinine in uremic whole blood leaving the hemodialyzer do not move down the concentration gradients established by loss of these solutes across the dialyzer membrane. This puzzling disequilibrium is at odds with work indicating ready movement of both solutes across the erythrocyte membrane of nonuremic erythrocytes studied in vitro. The present study shows that contact with the dialyzer does not noticeably alter the erythrocyte membrane of the uremic patient, so that urea distribution between plasma and erythrocyte water is the same as that in the blood of normal control subjects. Furthermore, urea does not show a disequilibrium in concentration across the erythrocyte membrane in response to 50% dilution with a modified Ringer's solution but rather equilibrates swiftly and completely.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6887697     DOI: 10.1038/ki.1983.108

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  4 in total

Review 1.  Searching for uremic toxins.

Authors:  Mirela Dobre; Timothy W Meyer; Thomas H Hostetter
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 8.237

Review 2.  An update on uremic toxins.

Authors:  N Neirynck; R Vanholder; E Schepers; S Eloot; A Pletinck; G Glorieux
Journal:  Int Urol Nephrol       Date:  2012-08-15       Impact factor: 2.370

3.  Methylamine clearance by haemodialysis is low.

Authors:  Manish P Ponda; Zhe Quan; Michal L Melamed; Amanda Raff; Timothy W Meyer; Thomas H Hostetter
Journal:  Nephrol Dial Transplant       Date:  2009-12-17       Impact factor: 5.992

4.  Solute mass balance during isovolaemic high volume haemofiltration.

Authors:  Shigehiko Uchino; Louise Cole; Hiroshi Morimatsu; Donna Goldsmith; Claudio Ronco; Rinaldo Bellomo
Journal:  Intensive Care Med       Date:  2003-07-10       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.